Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy

Springer Science and Business Media LLC - Tập 228 Số 6 - Trang 510-512 - 1990
Robert Gurny1, Jean-Etienne Ryser2, C. Tabatabay3, Myriam Martenet1, Peter Edman4, Ola Camber4
1Department of Pharmaceutical Technology, University of Geneva, Geneva 4, Switzerland
2Department of Nuclear Medicine, University Hospital of Geneva, Switzerland
3Department of Ophthalmology, University Hospital of Geneva, Switzerland.
4Department of Pharmaceutical R & D, Pharmacia-Leo Therapeutics AB, Uppsala, Sweden

Tóm tắt

Từ khóa


Tài liệu tham khảo

Barett TW (1976) The molecular dynamics of hyaluronates in solution. Biosystems 8:103?109

Camber O, Lundgren P (1985) Diffusion of some low molecular weight compounds in sodium hyaluronate. Acta Pharm Suec 22:315?320

Camber O, Edman P, Gurny R (1987) Influence of sodium hyaluronate on the miotic effect of pilocarpine in rabbits. Curr Eye Res 6:779?783

Gurny R, Ibrahim H, Aebi A, Buri P, Wilson CG, Washington N, Edman P, Camber O (1987) Design and evaluation of controlled release systems for the eye. J Controlled Release 6:367?373

Norn SM (1981) Perioperative protection of cornea and conjunctiva. Acta Ophthalmol 59:587?594

Polack MF, McNiece MT (1982) The treatment of dry eyes with Na hyaluronate (Healon®). Cornea 1:133?136

Robinson JR (1989) Ocular drug delivery mechanism(s) of corneal drug transport and mucoadhesive delivery systems. STP Pharma 5:839?846

Rozier A, Mazuel C, Grove J, Plazonnet B (1989) Gelvrite: a novel, ion-actived, in-situ gelling polymer for ophthalmic vehicoles. Effect on bioavailability of timolol. Int J Pharm 57:163?168

Saettone MF, Giannaccini B, Delmonte G, Campigli V, Tota G, La Marca F (1988) Solubilization of tropicamide by poloxamers: physicochemical data and activity data in rabbits and humans. Int J Pharm 43:67?76

Sand BB, Marner K, Norn MS (1989) Sodium hyaluronate in the treatment of kerato-conjunctivitis sicca. Acta Ophthalmol 67:181?183

Saric D, Reim M (1984) Behandlung von Verätzungen des vorderen Augenabschnitts mit hochpolymeren Na-Hyaluronat (Healon®). Fortschr Ophthalmol 81:588?591

Tabatabay C (1984) Utilisation du Healon® lors d'éépithélialisation cornéenne défectueuse. J Fr Ophtalmol 7:755

Tabatabay C (1985) Instillation d'acide hyaluronique à 0.1% lors de kératite sèche sévère. J Fr Ophthalmol 8:513

Tabatabay C, Ryser JE, Gurny R, Edman P, Camber O (1989) Precorneal residence time of sodium hyaluronate solutions measured by gamma scintigraphy. Invest Ophthalmol Vis Sci [Suppl] 30:248

Wysenbeek YS, Loya N, Ben Sira I, Ophir I, Ben Shaul Y (1988) The effect of sodium hyaluronate on the cornea epithelium. Invest Ophthalmol Vis Sci 29:194?199